Next Article in Journal
CD44-Receptor Targeted Gold-Doxorubicin Nanocomposite for Pulsatile Chemo-Photothermal Therapy of Triple-Negative Breast Cancer Cells
Next Article in Special Issue
Pharmacogenetic Dose Modeling Based on CYP2C19 Allelic Phenotypes
Previous Article in Journal
New and Old Horizons for an Ancient Drug: Pharmacokinetics, Pharmacodynamics, and Clinical Perspectives of Dimethyl Fumarate
Previous Article in Special Issue
Prospective Validation and Refinement of a Population Pharmacokinetic Model of Fludarabine in Children and Young Adults Undergoing Hematopoietic Cell Transplantation
 
 
Review

Article Versions Notes

Pharmaceutics 2022, 14(12), 2733; https://doi.org/10.3390/pharmaceutics14122733
Action Date Notes Link
article xml file uploaded 6 December 2022 15:18 CET Original file -
article xml uploaded. 6 December 2022 15:18 CET Update https://www.mdpi.com/1999-4923/14/12/2733/xml
article pdf uploaded. 6 December 2022 15:18 CET Version of Record https://www.mdpi.com/1999-4923/14/12/2733/pdf
article html file updated 6 December 2022 15:19 CET Original file -
article html file updated 1 March 2023 02:52 CET Update -
article html file updated 4 March 2023 01:45 CET Update https://www.mdpi.com/1999-4923/14/12/2733/html
Back to TopTop